Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

Oct 8, 2020

OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients

Sep 15, 2020

OPKO Health to Participate in Two September Investment Conferences

Sep 2, 2020

OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

Sep 2, 2020

OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay

Sep 1, 2020

OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services

Aug 12, 2020

OPKO Health to Participate in BTIG Virtual Biotechnology Conference

Aug 5, 2020

OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results

Jul 30, 2020

OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020

Jul 27, 2020

OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)

Jul 20, 2020
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...43
    Next
    © 2021 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap